Bibliografía
1.
Frémont B, Pacouret G, Jacobi D, Puglisi R, Charbonnier
B, de Labriolle A. Prognostic value of the
echocardiographic right/left ventricular end-diastolic
diameter ratio in patients with acute pulmonary
embolism: results from a monocenter registry of 1416
patients. Chest 2008;133:358-362.
2.
Braunwald E. Biomarkers in Heart Failure. Medical
progress. New England Journal of Medicine
2008;358:2148-59.
3.
Morrow DA, de Lemos JA.
Benchmarks for the assessment of novel cardiovascular
biomarkers. Circulation 2007;115:949-52.
4.
Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll
Cardiol 2007;50:2357-68.
5.
Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camaiti
A, Santoro G, Conti A, Agnelli G, Berni G. Short-term
clinical outcome of patients with acute pulmonary
embolism, normal blood pressure, and echocardiographic
right ventricular dysfunction. Circulation
2000;101:2817–822.
6.
Aujesky D, Obrosky S.D, Stone R.A. Derivation and
validation of a prognostic Model for pulmonary embolism.
Respiratory and Critical Care Medicine 2005;172:1041-46.
7.
Aujesky D, Roy PM, Le Manach C.P, Verschuren F.
Validation of a model to predict adverse outcomes in
patients with pulmonary embolism. European Heart
Journal 2006;27:476-81
8.
Tapson VF, Acute pulmonary embolism. New England Journal
of Medicine 2008;358:1037-52.
9.
Ten Wolde M, Söhne M, Quak E. Prognostic value of
echocardiographically assesed right ventricular
dysfunction in patients with pulmonary embolism.
Archives of internal Medicine 2004;164:1685-1689.
10.
Kucher N, Rossi E, De Rosa M, Goldhaber S Z. Prognostic
Role of Echocardiography among patients with acute
pulmonary embolism and a systolic arterial pressure of
90 mmHg or higher. Archives of internal medicine
2005;165:1777-81
11.
Maziere F, Birolleau S, Medimagh S. Comparison of
troponin I and N-terminal-pro B-type natriuretic peptid
for risk of stratification in patients with pulmonary
embolism. Europe Journal Emergency Medicine 2007;
14:207-11.
12.
Kucher N, Printzen G, Doernhoefer T. Low pro-brain
natriuretic peptide levels predict benign clinical
outcome in acute pulmonary embolism. Circulation 2003;
107:1576-78.
13.
Klok F.A., Mos I.C.M, Huisman M. V. Brain Type
Natriuretic Peptide levels in The Prediction of Adverse
Outcome in Patients with Pulmonary Embolism. A
Systematic Review and Meta Analysis. American Journal Of
Respiratory Crit Care Medicine. 2008;178:425-430.
14.
Kucher N, Printzen G,
Goldhaber SZ. Prognostic Role of Brain Natriuretic
Peptide in Acute Pulmonary Embolism. Circulation
2003;107:2545-2547.
15.
Binder L, Pieske B, Olschewski M, Geibel A, Klostermann
B, Reiner C. N-Terminal Pro Brain Natriuretic Peptide or
Troponin Testing Followed by Echocardiographic for Risk
Stratification of Acute Pulmonary Embolism. Circulation
2005;112:1573-1579.
16.
Söhne M, Ten Wolde M, Boomsma F, Reitsma J. B, Douketis§
J. D. and Büller R. Brain natriuretic peptide in
hemodynamically stable acute pulmonary embolism. Journal
of Thrombosis and Haemostasis 2006; 4: 552–556.
17.
Pieralli F, Olivotto I,Vanni S,Conti A. Usefulness of
Bedside Testing for Brain Natriuretic Peptide to
Identify Right Ventricular Dysfunction and Outcome in
Normotensive Patients With Acute Pulmonary Embolism.
American Journal of Cardiology 2006;97:1386-1390.
18.
Ray P, Maziere F, Medimagh S, Lefort Y, Arthaud M,
Duguet A. Evaluation of B-type natriuretic peptide to
predict complicated pulmonary embolism in patients aged
65 years and older: brief report.
American Journal of Emergency Medicine (2006) 24,
603–607.
19.
Coutance G, Le Page O, Lo
T, Hamon M. Prognostic Value of Brain Natriuretic
Peptide in Acute Pulmonary Embolism. Critical Care
2008;12(4).
20.
Tibbutt DA, Davies JA, Anderson JA, et al.
Comparison by controlled clinical trial of streptokinase
and heparin in treatment of life threatening pulmonary
embolism. Br Med J 1974;1:343-7.
21.
Levine M, Hirsh J, et al. A randomized trial of a single
bolus dosage regimen of recombinant tissue plasminogen
activator in patients with acute pulmonary embolism.
Chest 1990;98:1473-9.
22.
Konstantinides S, Geibel A,
et al. Management Strategies and Prognosis of Pulmonary
Embolism-3 trial investigators (MAPPET- 3). Heparin plus
alteplase compared with heparin alone in patients with
submassive pulmonary embolism. N Engl J Med
2002;347:1143-50.
23.
Cavallazzi R, Nair A, Vasu
T, Marik P.E. Natriuretic Peptides in Acute Pulmonary
Embolism: a Systematic Review. Intensive Care Medicine.
2008;34(12):2147-2156.
24.
Fengler B.T., Brady W.J.
Fibrinolytic Therapy in Pulmonary Embolism: an
evidence-based treatment algorithm. American Journal of
Emergency Medicine 2009;27:84-95.
25.
Dotsenko O, Chackathayil
J., Gregory YH Lip. Cardiac biomarkers: Myths, facts and
future horizons. Experts Reviews of molecular diagnosis.
En
http://medscape.com/viewarticle/566697
26.
Carreiro-Lewandowski E. Update on Cardiac biomarkers.
En
http://medscape.com/viewarticle/545526
